Impact of fasting glucose on electrocardiographic left ventricular hypertrophy in an elderly general population

Blood Press. 2015 Jun;24(3):164-73. doi: 10.3109/08037051.2015.1030892. Epub 2015 Apr 17.

Abstract

Objective: To evaluate relationships between fasting plasma glucose (FPG), other cardiovascular risk markers and left ventricular hypertrophy (LVH) as detected by electrocardiography.

Methods: Subjects were selected randomly from groups defined by FPG. Traditional risk markers were assessed. LVH was defined by either Cornell voltage-duration product (CP) or Sokolow-Lyon voltage combination (SL), and univariate and multivariable regressions were performed in search of explanatory factors for the presence of LVH and the values of CP and SL.

Results: Of the 1759 subjects included, 1007 had a history of cardiovascular disease and/or medical treatment, while 752 subjects appeared to be healthy. We found an independent association between FPG and LVH (odds ratio 1.152, p = 0.042] as well as continuous CP (beta = 0.126, p = 0.007) in healthy men. As expected, we found an association between systolic blood pressure and LVH (odds ratio 1.020, p < 0.001) among healthy subjects, but only in subjects with FPG < 6 mmol/l (p = 0.04 for interaction).

Conclusions: We found an independent association between FPG and LVH in healthy men, and no potentiating effect by FPG on the impact of hypertension.

Keywords: Aged; diabetes mellitus; electrocardiography; glucose; hypertension; left ventricular hypertrophy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Blood Glucose / metabolism*
  • Cardiomegaly* / blood
  • Cardiomegaly* / physiopathology
  • Electrocardiography*
  • Fasting / blood*
  • Female
  • Humans
  • Hypertension* / blood
  • Hypertension* / physiopathology
  • Male
  • Middle Aged

Substances

  • Blood Glucose